KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Non-cash Items (2020 - 2023)

Ginkgo Bioworks Holdings filings provide 4 years of Non-cash Items readings, the most recent being $14.6 million for Q2 2023.

  • On a quarterly basis, Non-cash Items fell 21.13% to $14.6 million in Q2 2023 year-over-year; TTM through Jun 2023 was $14.6 million, a 21.13% decrease, with the full-year FY2022 number at $9.5 million, down 57.37% from a year prior.
  • Non-cash Items hit $14.6 million in Q2 2023 for Ginkgo Bioworks Holdings, up from $8.4 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $386.0 million in Q4 2020 to a low of $8.4 million in Q1 2023.
  • Median Non-cash Items over the past 4 years was $22.4 million (2021), compared with a mean of $68.2 million.
  • Biggest five-year swings in Non-cash Items: plummeted 94.2% in 2021 and later soared 74.7% in 2022.
  • Ginkgo Bioworks Holdings' Non-cash Items stood at $386.0 million in 2020, then plummeted by 94.2% to $22.4 million in 2021, then plummeted by 57.37% to $9.5 million in 2022, then skyrocketed by 53.12% to $14.6 million in 2023.
  • The last three reported values for Non-cash Items were $14.6 million (Q2 2023), $8.4 million (Q1 2023), and $9.5 million (Q4 2022) per Business Quant data.